Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 20,137-20,148 of 23,847
Drug study icon
TerminatedNCT01122927

Safety study of aripiprazole in schizophrenia

This study was terminated in the United States, in Bulgaria, in Croatia, .... It is testing aripiprazole for schizophrenia.

Multiple locations, including Dothan
Bipolarity, SchizophreniaDrugFrom 10 Years to 17 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT01892384

Safety and Tolerability of BI 409306 in people with Schizophrenia

This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

In Austin
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
Drug study icon
CompletedNCT03238326

Open-Label Flexible-dose Brexpiprazole for schizophrenia

This study is completed in the United States, in France, in Italy, .... It is testing Open-Label Flexible-dose Brexpiprazole for schizophrenia.

Multiple locations, including Dothan
SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States, France, Italy, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
WithdrawnNCT05562973

Safety and Tolerability of Psilocybin in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
PTSDDrugFrom 18 Years to 80 Years
Countries
Sponsor
Johns Hopkins University
Condition
PTSD
Drug study icon
CompletedNCT02773576

Safety and Tolerability of Risperidone Implants

This summary needs review. Please check the official study record and contact the research team for details.

In Garden Grove
SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Braeburn Pharmaceuticals
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.